Post-earnings recap
Reported
Wed, Nov 9, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CorMedix Inc. reported a larger-than-expected loss per share for Q3 2016, which typically raises concerns among investors. However, the stock reacted positively, increasing by 3.67%. This could indicate that investors are optimistic about other aspects of the company's performance or future potential, despite the EPS miss.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.23 | N/A | -53.33% |
| Revenue | $— | N/A | N/A |
No transcript is on record for the earnings call, and the analysis is based solely on numerical results.